Investigation of the influence of anti-glaucoma eyedrops on corneal stroma and corneal shape

Investigation of the influence of anti-glaucoma eyedrops on corneal stroma and corneal shape - The influence of anti-glaucoma eyedrops on corneal stroma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000030262

Enrollment

300

Registered

2017-12-08

Start date

2017-12-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Use of one kind of anti-glaucoma eyedrops for more than 3 months on one or both eyes. Or no use of anti-glaucoma eyedrops.

Exclusion criteria

Exclusion criteria: 1. History of surgery including laser surgery within 3 months. 2. History of corneal or conjunctival surgery. 3. History of glaucoma surgery. 4. History of surgery for lacrimal drainage. 5. History of contact lens use during the recent 1 month. 6. Existence of inflammatory disease in the anterior segment of the eye. 7. Use of combined eyedrop of prostaglandin and beta-blocker.

Design outcomes

Primary

Measure	Time frame
deformation amplitude	—

Countries

Japan

Contacts

Public Contactshiro Amano

Inouye Eye Hospital Ophthalmology

amanoshiro1126@gmail.com03-3295-0925

Outcome results